Sunshine Biopharma, Inc.
SBFM
$1.48
$0.085.71%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.99M | -6.31M | -5.03M | -5.13M | -4.23M |
| Total Depreciation and Amortization | 298.90K | 267.30K | 245.70K | 223.50K | 200.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.62M | 1.06M | 0.00 | 12.00K | 12.40K |
| Change in Net Operating Assets | -3.05M | -2.77M | -6.27M | -7.63M | -7.80M |
| Cash from Operations | -7.12M | -7.75M | -11.06M | -12.53M | -11.81M |
| Capital Expenditure | -278.10K | -787.10K | -1.60M | -1.66M | -1.17M |
| Sale of Property, Plant, and Equipment | 10.30K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.05M | -1.08M | -318.70K | -756.00K | -978.70K |
| Cash from Investing | -1.32M | -1.87M | -1.92M | -2.41M | -2.15M |
| Total Debt Issued | 347.90K | 347.90K | 347.90K | 347.90K | -- |
| Total Debt Repaid | 87.80K | 70.50K | 100.30K | 87.90K | -32.90K |
| Issuance of Common Stock | 5.64M | 7.54M | 3.87M | 12.08M | 10.47M |
| Repurchase of Common Stock | 0.00 | 0.00 | 0.00 | -3.14M | -3.14M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 6.08M | 7.96M | 4.32M | 9.38M | 7.29M |
| Foreign Exchange rate Adjustments | -538.10K | 462.50K | -651.10K | -1.04M | 27.60K |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash | -2.90M | -1.20M | -9.31M | -6.61M | -6.64M |